Smoking rates point to promoting cessation
This article was originally published in The Tan Sheet
Executive Summary
Research showing smoking rates of U.S. adults are not declining could elevate FDA's authority to approve smoking-cessation products under the tobacco control act. The Centers for Disease Control and Prevention Nov. 13 said data from the 2008 National Health Interview Survey show little to no change in smoking rates in the past five years. The study found 46 million U.S. people (20.6 percent) were smokers in 2008, essentially the same as the 2004 rate of 20.9 percent. The Family Smoking Prevention and Tobacco Control Act directs FDA to consider changing the way it reviews smoking cessation products, which would allow the agency to create opportunities for new products and expand markets for existing products (1"The Tan Sheet" Sept. 7, 2009)
You may also be interested in...
Tobacco Law Means Drug Sponsor Opportunities May Not Stop At Cessation
The tobacco control act prompts FDA to consider new indications - such as smoking reduction - for smoking cessation products, which could lead to new criteria for application approval
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.